This is a multicenter, double-blind, placebo-controlled phase 3 study to demonstrate the efficacy and safety of an investigational drug, ACT-293987, in patients with pulmonary arterial hypertension.

For more information, contact Melissa Willis, RN, at 919-684-6237.